Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Exclusion Criteria

• •This is a multi-organ transplant or if the patient has previously been transplanted with any other organ.
• •This is a liver transplant from a non-heart beating donor.
• •This is an ABO incompatible transplant.
• •Patients with serum creatinine level \> 250 umol/L.
• •The recipient is seropositive for human immunodeficiency virus (HIV) antibodies.
• •Fulminant liver failure is the reason for transplant.
• •Patient is participating in other clinical trial involving exploratory drug
• •There is a known malignancy, or a history of malignancy, other than successfully treated non-metastatic basal or squamous cell carcinoma of the skin, or hepatocellular carcinoma less than 5 cm meeting Milan criteria for transplantation5.
• •The patient is being transplanted for hepatic malignancy with greater than 5 known lesions.
• •Severe coexisting disease is present or if any unstable medical condition is present which could affect the study objectives.
• •A female transplant candidate is pregnant, lactating or of childbearing potential and not practicing an acceptable method of contraception.
• •An unlicensed drug or therapy has been administered within one month prior to study entry or if such therapy is to be instituted post-transplantation.